Joint Transnational Call 2026: Treatments and Adherence to Treatment Protocols

Eligibility

Funding recipients

Joint research proposals may be submitted by partners belonging to the following categories:

• Academia (public and private universities, other higher education institutions or research institutes).
• Clinical/public health sector (hospitals/public health and/or other health care settings and health organisations, including primary health care).
• Enterprises (private companies of all sizes involved in research and innovation).
• Operational stakeholders – e.g. patient advocacy organisations, municipalities and local governments, local/national NGOs. Operational stakeholders should be able to provide useful knowledge to the consortium, ensure the consortium’s research is useful and translatable to their (or other) organisational contexts, and/or influence decision making or create change within their organisations. Operational stakeholders should be engaged in the research process from conception of the study to dissemination.

Each partner institution will be represented by one (1) Principal Investigator who will be the researcher scientifically responsible for the implementation of tasks assigned.

Composition of the transnational consortium

To be eligible, the submitted pre-/full proposals must respect the following eligibility rules regarding the composition of their consortium. Consortia not respecting the eligibility rules will be rejected without further review.

• The consortium must include a minimum of three (3) eligible partners asking for funding from three (3) different eligible countries (including at least two amongst EU Member States or Associated Countries).
• The consortium can include a maximum of six (6) project partners, including non-funded partners.
• The maximum number of partners can be increased to seven (7) if the consortium includes:
  • at least one partner from an under-represented country (For the purpose of this call, the under-represented countries are: Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Moldova, Poland, and Slovakia) or
  • at least one partner where the Principal Investigator meets the definition of an Early-Career Researcher or
  • a start-up, SME, or an Industry.
• A consortium cannot include more than two (2) partners requesting funding from the same funding organisation. Please note that for United Kingdom partners, the limit of two applies to both UK funding organisations, meaning that the consortium cannot include more than two UK partners funded either by MRC-UKRI or by Innovate-UK.
• A principal investigator can coordinate only one (1) submitted pre-proposal/ full proposal.

Modification of the composition of the transnational consortium

The composition of the consortium should not be modified between the pre- and the full proposal except for:

• widening (see next section)
• in case of force majeure/unforeseen event (e.g. change of professional affiliation, lab relocation, prolonged absence of the Principal Investigator, etc.)
• upon recommendation of the Peer Review Panel or request of the Call Steering Group

National Rules and Requirements: 

• All Countries: National Rules and Requirements - EUP OHAMR
• Canada: JTC 2026 - Canada National rules and requirements - EUP OHAMR

Summary

Aim of the call

Drug-resistant infections are responsible for an increasing number of treatment failures, increased mortality and decreased food productivity. Inappropriate use, poor adherence to prescriptions, and overuse of antibiotics are one of the main drivers of AMR and have a detrimental impact on the effectiveness of these critical medicines.

To develop novel treatment protocols or alternative treatment strategies against infectious diseases and to improve, preserve and reinforce the clinical efficacy of the current treatment antimicrobials is vital. It is also necessary to identify barriers preventing the proper adherence of the end-users to the treatment protocols already in place.

This first EUP OHAMR Call aims to improve the treatment success rates of the patients/animals/plants affected by bacterial or fungal infections by providing new treatment options while reducing the risk of resistance in the different One Health settings.

Call topics 

*NOTE: Consistent with the One Health approach embedded within the Pan-Canadian Action Plan on AMR and prioritized within CIHR-III’s Strategic Plan for 2021-2026, projects must be relevant to Call Topic 3 to receive CIHR funding. Projects addressing call topic 3 are eligible for funding, provided they include human health research activities. Projects can include only one (1) Canadian component.

Research & innovation proposals submitted under this call must address one of the following topics:

Topic 1: Identify and develop new combination treatments using existing or innovative antimicrobials or antimicrobial with adjunctive treatments to extend drug efficacy and combat resistance.

Topic 2: Develop tools and methods to improve adherence to treatment protocols.

Topic 3*: Assess the impact of antimicrobials for veterinary and agricultural use on the risk of AMR transmission to humans and the environment to inform policies on the restriction of some antimicrobials for human use.

Requirements for all call topics

The following requirements applies for all call topics:

• Proposals should consider how the proposed approach will impact the risk of resistance in other One Health settings, and how the proposed approach could be extended to other One Health settings.
• Proposals should explain their feasibility by outlining realistic objectives, practical methodologies, and achievable timelines (e.g.: workplan, risk identification, allocation of resources, capacity of the consortium to conduct the work, business plan if the proposal envisages commercial component, etc).
• Proposals must clearly demonstrate the potential health, social and/or economic impact(s) of the expected results. In particular, the proposals should explain how the uptake of the expected project results by the society/ end-users/ next actors in the value chain will be facilitated.
• Proposals should clearly demonstrate the benefit of working together and the unique contribution of each partner (i.e. expertise, resources). In addition, the proposals should demonstrate the added-value of transnational collaboration: sharing of expertise and resources (models, databases…), harmonization of data, access to innovative technologies, etc.
• Participation of the private sector (start-up, SMEs, industry) in the consortium is encouraged for all call topics if appropriate and if allowed according to national funding eligibility rules.

Application procedure

Pre-proposals and full proposals must be submitted by the project coordinator on the EUP OHAMR on-line submission platform. No other means of submission (i.e. post or e-mail) will be accepted. Please note that some funding organisations might request an additional mandatory submission on their own national/regional platform. Pre-/full proposals submitted on a national/regional platform but not on the EUP OHAMR submission platform will be rejected without further review.

Applicants must respect the submission deadlines indicated. Submission of pre-proposals or full proposals after the submission timeline will not be accepted.

Applicants must consider enough time to complete the information on-line. In particular, please consider that collecting some information, such as the Participant Identification Code (PIC) of your research organisation, may require external procedure. Applicants should also ensure that they will have a proper internet connection at the time of submission.

Letter of intent

At both the pre- and full proposal stages, all partners, including non-funded partners, must submit a signed letter of intent along with their pre-/full proposal (the templates to be used for the letters of intent are included in the pre-/full proposal templates).

In the absence of these letters, the proposal will be declared ineligible. At the pre-proposal stage, the letter of intent must be signed by the project investigators representing the different partner institutions. At the full proposal stage, the letter of intent should also be signed by a person having the legal mandate to represent the partner institutions.

Pre-application deadlines

RSO internal deadline

Pre-application program deadline

Application deadlines

RSO final internal review deadline

Program application deadline

NOTE: Consult your Faculty Associate Dean (Research) (ADR) regarding Faculty-specific deadlines and submission processes.

Principal Investigators: Complete a Research Management System (RMS) record, including a copy of your complete application, and submit this for approvals in RMS.

Postdocs, students, and trainees: For fellowships and externally-sponsored research training awards or opportunities, you must complete the Research Funding Application Approval (RFAA) Trainee PDF form, and submit it, along with a complete copy of the application, to Research Services at rsotrainee@ucalgary.ca. Trainees should not use RMS at this time.

Approvals: The University of Calgary requires that all funding applications be approved prior to submission. Approval requires signatures via either RMS or the RFAA Trainee form, in the following order:

• Principal Investigator
• Department Head
• Faculty ADR/Dean
• Research Services (on behalf of the Vice-President Research)

Read the Meaning of Grant Signatures policy to understand what your approval means. Please see the agency guidelines for details about which signatures are required on your application, as it may differ from internal requirements.

Late submissions: Late submissions will only be accepted in cases of medical or family emergencies, or other exceptional circumstances. If you submit your RMS record to Research Services after the internal deadline has passed, you must secure additional approvals. Please read: Late Applications Process.

RESOURCES

Reminder: The sooner the researcher engages with Research Services, the more help we can be!

Contact the following Research Service units for support with:

Projects Involving Indigenous Research:

Support with incorporating wise practices in Indigenous research, community engagement, and Indigenous data management is available through the Indigenous Research Support Team (IRST).

Applicants can reach out by email to IRST at IRST@ucalgary.ca in advance of the RSO internal deadline. For more information about IRST, please visit the IRST webpage.

Knowledge Mobilization, Research Impact Assessment, DORA:

Support for knowledge mobilization/engagement/translation, community partnerships, research impact, responsible research assessment (DORA), and open science, is available through the Knowledge to Impact team.

Applicants can reach out by email to the KI team at knowledge.impact@ucalgary.ca.

For more information and access to resource archives, please visit the KI team webpage.

Research Data Management:

For information on research data management plans, processes, or best practices for your research program, please contact research.data@ucalgary.ca.

EDI in Research:

RSO can provide resources and support to research teams on the integration of equitable and inclusive practices in research design and research practice.

Contact edi.rso@ucalgary.ca for more information.

Research Security:

The Research Security Division is available to ensure researchers adhere to research security guidelines and policies, including the National Security Guidelines for Research Partnerships (NSGRP) and the policy on Sensitive Technology Research and Affiliations of Concern (STRAC).

Visit the Research Security website to learn more or contact researchsecurity@ucalgary.ca.

Pre-Award Submissions:

RMS: Creating a Pre-Award LOI
RMS: Creating a Pre-Award Application